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Dentinogenic effects of extracted 
dentin matrix components digested 
with matrix metalloproteinases
Motoki Okamoto1, Yusuke Takahashi1, Shungo Komichi1, Paul R. Cooper2 & Mikako Hayashi1
Dentin is primarily composed of hydroxyapatite crystals within a rich organic matrix. The organic 
matrix comprises collagenous structural components, within which a variety of bioactive molecules 
are sequestered. During caries progression, dentin is degraded by acids and enzymes derived from 
various sources, which can release bioactive molecules with potential reparative activity towards 
the dentin-pulp complex. While these molecules’ repair activities in other tissues are already known, 
their biological effects are unclear in relation to degradation events during disease in the dentin-pulp 
complex. This study was undertaken to investigate the effects of dentin matrix components (DMCs) 
that are partially digested by matrix metalloproteinases (MMPs) in vitro and in vivo during wound 
healing of the dentin-pulp complex. DMCs were initially isolated from healthy dentin and treated 
with recombinant MMPs. Subsequently, their effects on the behaviour of primary pulp cells were 
investigated in vitro and in vivo. Digested DMCs modulated a range of pulp cell functions in vitro. In 
addition, DMCs partially digested with MMP-20 stimulated tertiary dentin formation in vivo, which 
exhibited a more regular tubular structure than that induced by treatment with other MMPs. Our results 
indicate that MMP-20 may be especially effective in stimulating wound healing of the dentin-pulp 
complex.
When a tooth is damaged by caries and/or fracture, underlying pulp tissue can become exposed. In this situa-
tion, direct pulp capping is the only treatment option that enables preservation of pulp vitality and activation of 
dentin regeneration1. Pulp capping involves the placement of a protective dressing over the exposed pulp area to 
stimulate tertiary dentin formation. Calcium hydroxide [Ca(OH)2] has long been considered the gold standard 
of pulp capping materials; more recently, mineral trioxide aggregate (MTA) has found wide clinical use for this 
application2,3. Although these materials exhibit relatively high success rates (60%–80%)4, neither material was 
originally developed to induce cellular repair of the dentin-pulp complex; such treatment should be based on 
the key biological events associated with tissue repair. Our understanding of tertiary dentinogenesis, as well as 
our ability to modify this process within the clinical setting, remain incomplete; this constrains the development 
of optimal pulp capping materials that are compatible with the biological events occurring during dentin-pulp 
repair and regeneration5–7.
Therefore, we aimed to determine how MMPs may influence tertiary dentinogenic events to support the 
development of a new generation of biologically-based pulp capping materials. We previously reported that 
matrix metalloproteinases (MMPs) are involved in wound healing within the dentin-pulp complex8. Notably, 
the integrity of the extracellular matrix (ECM) of many organs can be affected by MMPs and tissue inhibitor 
of metalloproteinases (TIMPs), both of which play critical roles in matrix remodeling9–11 by regulating ECM 
digestion12,13. Indeed, when ECM from heart, kidney, skin, bladder, or skin tissues were digested enzymatically 
or treated with acid, they released ECM molecules and molecular or peptide fragments, including growth factors 
and other signalling molecules reported to significantly enhance tissue repair-associated cellular activities14–16. 
During caries the dissolution of dentin matrix by bacterial acids and hydrolytic enzymes leads to the release of 
dentin matrix components (DMCs), as well as partially digested molecular components17. In addition, several 
MMPs are reported to be constituents of the dentin-pulp complex17–20; MMPs can further induce the activity 
of bacterial enzymes, which may result in activation of latent hydrolytic enzymes. Subsequently, the combined 
effects of activated bacterial enzymes and MMPs, specifically regarding the partial cleavage of molecules within 
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the dentin matrix, could influence signalling aspects of tertiary dentinogenesis. This supports the concept that 
bioactive molecules within the dentin matrix can exert signalling properties when not intact.
While bacterial and host enzymes are important for caries progression21, their exact role in hard tissue forma-
tion in the dentin-pulp complex remains unclear. Additionally, it is unclear whether partial digestion of DMCs 
impacts their bioactive properties and their effects on wound healing in the dentin-pulp complex. Therefore, we 
hypothesize that DMCs digested with MMPs can enhance tertiary dentinogenic events in the dentin-pulp com-
plex. In this study, we investigated the effects of partially MMP-digested DMCs on pulp cell functions related to 
wound healing in vitro and wound healing in the dentin-pulp complex in vivo.
Results
Protein profile of digested DMCs. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) showed that DMCs were partially digested by MMP-1, -2, -3, -8, -9, -13, or -20 after 1- and 24-h incuba-
tion, compared with undigested DMCs; longer incubation periods resulted in greater digestion. Representative 
protein profiles following MMP-1 and −2 treatments for 1 and 24 h are shown in Fig. 1A,B (red arrowheads), 
respectively. DMC samples incubated in the absence of MMPs for the same period of time serve as controls for 
the effects of any endogenous enzyme activities within the DMC preparations. In subsequent experiments, DMCs 
treated with MMPs for 24 h were analysed to enable the study of the effects of long-term digestion. Other MMPs 
also showed distinctive digestion profiles (Supplementary Figs 1–3).
Angiogenesis assay. Angiogenesis was evaluated in terms of tubular area, including analysis of three 
parameters: vessel number, branch length, and branch point. One microgram per millilitre of DMCs digested 
with MMP-1, -2, or -3 promoted tubule formation, compared with 1 µg/ml of incubated DMCs without MMP 
digestion. Suramin was used as a negative control and vascular endothelial growth factor (VEGF) was applied 
as a positive control (Fig. 2A,B). No significant differences were observed between DMCs treated with MMP-8, 
Figure 1. Protein profiles (silver staining) of dentin matrix components (DMCs) treated with matrix 
metalloproteinase (MMP)-1 (A) or MMP-2 (B) are shown as a merged view by combining images of the 
cropped blots and gels. Dotted lines indicate the borders of the cropped blots. The incubation time influenced 
the protein profile. Red arrowheads indicate the differences between protein profiles of MMP-treated DMCs 
following 1- and 24-h incubation. Light blue arrowhead indicates pro form of predicted MMP-1 and MMP-2, 
respectively. Black arrowhead indicates active form of predicted MMP-1 and MMP-2. Original full blots/gels are 
presented in Supplementary Fig. 13.
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Figure 2. In vitro angiogenesis assay. (A) Representative CD31 immunostaining image after 11-day culture in 
the presence of 1 μg/ml of dentin matrix components (DMCs) treated with matrix metalloproteinases (MMP)-
1, -2 and -3, incubated DMCs without MMP were used, 20 µM/L suramin as a negative control or 2 ng/ml of 
vascular endothelial growth factor (VEGF) as a positive control (×40). (B) Quantification of tubule formation. 
One microgram per millilitre of DMCs treated with MMP-1, -2, and -3 significantly promoted angiogenesis, 
compared with the negative control, DMCs incubated without MMP and MMPs incubated alone (p < 0.05). 
No significant differences were observed with 1 µg/ml of DMCs treated with the other MMPs, MMPs incubated 
alone or at lower concentrations (0.01–0.1 µg/ml) of the above-described MMPs. Groups with similar lower-
case letters (i.e., a and b) are not significantly different. Data represent three independent experiments.
www.nature.com/scientificreports/
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-9, -13, or -20 and the experimental control, regardless of the concentration applied. Additionally, lower concen-
trations of DMCs (0.01–0.1 µg/ml) treated with MMP-1, -2, or -3 resulted in similar levels of tubule formation, 
compared with experimental controls (Supplementary Fig. 4). However, 1 µg/ml of DMCs digested by MMP-1, -2, 
or -3 showed significantly increased tubule formation, compared with experimental controls (p < 0.05) (Fig. 2B). 
Each MMP molecule incubated alone (0.01–1 µg/ml) was used as an additional control and showed no effect in 
the angiogenesis assay.
Migration assay. Pulp cell migration plays a critical role in repair and regeneration22. In the present study, 
two different experimental approaches were used to study migration. The horizontal scratch wound assay allowed 
direct visualization of the effects of 1 µg/ml of DMCs treated with MMP-1, -3, or -9 on promotion of cell migra-
tion; there was a significant difference, compared with 1 µg/ml of incubated DMCs without the addition of MMPs 
(p < 0.05) (Fig. 3B,D,F). Control medium (α-minimum essential medium (MEM) containing 1% fetal bovine 
serum (FBS)) was used as a negative control. Trans-well assays showed significant chemotactic effects of 1 µg/
ml of DMCs treated with MMP-1, -3, -9, or -20, compared with an experimental control and negative control 
(p < 0.05) (Fig. 3E). No significant differences were observed in 1 µg/ml of DMCs digested by MMP-2, -8 or 
-13 samples, nor were differences observed at lower concentrations (0.01–0.1 µg/ml) of MMP-treated DMCs 
(Supplementary Fig. 5). Each MMP molecule incubated alone (0.01–1 µg/ml) was used as an additional control 
and showed no effect in the migration assay.
Figure 3. Effects of 1 µg/ml of dentin matrix components (DMCs) treated with matrix metalloproteinases 
(MMPs) on wound scratch (B–H) and chemotactic (I) cell migration. Eight points were randomly selected to 
assess wound scratch migration; the distances of the cells from the edge of the scratch wound were measured 
by microscopic observation (A). Wound scratch migration of cells incubated with 1 µg/ml DMCs treated with 
MMP-1 (B), MMP-2 (C), MMP-3 (D), MMP-8 (E), MMP-9 (F), MMP-13 (G) and MMP-20 (H) is presented 
as the amount of movement, and chemotactic migration of cells incubated with 1 µg/ml DMCs treated with 
MMP-1, MMP-2, -3, -8, -9, -13, and -20 is presented as relative fluorescence units (RFU) (I). One microgram 
per millilitre of DMCs treated with MMP-1, -3, or -9 promoted horizontal migration, compared with 1 µg/ml of 
incubated DMCs without the addition of MMPs (p < 0.05). The trans-well assay demonstrated the significant 
chemotactic effects of 1 µg/ml of DMCs treated with MMP-1, -3, -9, or -20, compared with the experimental 
and negative controls (p < 0.05). Significant differences were not observed with 1 µg/ml DMCs treated with 
other MMPs, MMPs incubated alone or at lower concentrations (0.01–0.1 µg/ml) of the above-mentioned 
MMPs. Groups with similar lower-case letters (i.e., a and b) are not significantly different. Data represent five 
independent experiments.
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Proliferation assay. Pulp cell proliferation was promoted by 1 µg/ml of DMCs treated with MMP-1, -8, 
-9, or -13, compared with DMCs incubated without MMPs (experimental control) and α-MEM containing 1% 
FBS (negative control) (p < 0.05) (Fig. 4). However, 1 µg/ml of DMCs treated with MMPs-2, -3, or -20, as well as 
lower concentrations (0.01–0.1 µg/ml) of MMP-treated DMCs, did not significantly promote cell proliferation 
(Supplementary Fig. 6). Each MMP molecule incubated alone (0.01–1 µg/ml) was used as an additional control 
and showed no effect in the proliferation assay.
ALP activity. On day 7, primary pulp cells incubated with 1 µg/ml of DMCs treated with MMP-1 or MMP-
20 showed higher alkaline phosphatase (ALP) activities, compared with incubated DMCs without MMPs 
(experimental control) and α-MEM containing 1% FBS (negative control) (p < 0.05) (Fig. 5). One microgram 
per millilitre of DMCs treated with MMP-2, -8, -9, or -13 did not promote ALP activity in pulp cell cultures 
by day 7, compared with controls. On day 14, DMCs treated with MMP-9 and -13 also stimulated pulp cell 
ALP activity, similar to MMP-1 and -20 (p < 0.05) (Fig. 5). Significant differences were not observed in 1 µg/ml 
of DMCs treated with MMP-2 or MMP-8, or at lower concentrations (0.01–0.1 µg/ml) of MMP-treated DMCs 
(Supplementary Figs 7 and 8). Each MMP molecule incubated alone (0.01–1 µg/ml) was used as an additional 
control and showed no effect in the ALP activity assay.
Mineralization assay. DMCs (1 µg/ml) treated with MMP-1, -9, -13, or -20 significantly promoted mineral-
ized nodule formation in pulp cell cultures after incubation for 21 days, compared with DMCs incubated without 
MMPs (experimental control) and α-MEM containing 1% FBS (negative control) (p < 0.05) (Fig. 6). However, 
significant differences were not observed in pulp cell cultures treated with 1 µg/ml of DMCs treated by MMP-2, 
-3, or -8, or at lower concentrations (0.01–0.1 µg/ml) of MMP-treated DMCs (Supplementary Fig. 9). Each MMP 
molecule incubated alone (0.01–1 µg/ml) was used as an additional control and showed no effect in the mineral-
ization assay.
Evaluation of tertiary dentin formation by direct pulp capping in vivo. To evaluate whether DMCs 
treated with MMPs were able to stimulate tertiary dentin formation, a direct pulp capping experiment, which is a 
standard method in the dental field, was performed5,6. Representative micro-CT images of tertiary dentin 28 days 
after pulp capping by using 1 µg/ml of DMCs treated with MMP-1 (A), MMP-2 (B), MMP-3 (C), MMP-8 (D), 
MMP-9 (E), MMP-13 (F), MMP-20 (G), or DMCs without MMP (H) are shown in Fig. 7A–H. Quantification of 
tertiary dentin is shown in Fig. 7I. Tertiary dentin formation induced by 1 µg/ml of DMCs treated with MMP-
1, -9, -13, or -20 was enhanced, compared with DMCs treated with other MMPs, or without MMP treatment 
(p < 0.05). MMP-20-treated DMCs induced hard tissue formation with fewer defects, compared with tertiary 
dentin induced by MMP-1, -9, or -13, which showed larger defects or a void space beneath the pulp-capping 
material. As a reference, representative micro-CT and histological images of tertiary dentin 28 days after pulp 
capping with MTA and incubation with MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, or MMP-20 alone 
are shown in Supplementary Fig. 11; MTA induced highly dense tertiary dentin without significant defects.
These data represent six independent experiments. Representative histological images of haematoxylin and 
eosin (HE)-stained teeth, 28 days after pulp capping, highlighted the positive effects of treatment with 1 µg/ml 
of MMP-treated DMCs (Fig. 8). One microgram per millilitre of DMCs treated with MMP-1 (Fig. 8A), MMP-9 
(Fig. 8E), MMP-13 (Fig. 8F), or MMP-20 (Fig. 8G) stimulated pulp tissue repair, compared with 1 µg/ml DMCs 
treated with other MMPs, based on the coverage of the exposed pulp by a tertiary dentin bridge (p < 0.05) 
(Tables 1 and 2). Tubular structure and defects or continuous nature of tertiary dentin are commonly used to 
assess quality of tertiary dentin. According to these criteria, the tubular regularity of tertiary dentin formation 
stimulated by 1 µg/ml of DMCs treated with MMP-1, -9, -13, and -20 was superior to the formation stimulated 
by MMP-2, -3, or -8, as well as 1 µg/ml of DMCs without addition of MMPs (experimental control) or PBS 
(negative control) (p < 0.05). In particular, 1 µg/ml of DMCs treated with MMP-20 resulted in increased ter-
tiary dentin formation and enhanced tubular structure (Fig. 8I), compared with DMCs treated with other MMPs 
(p < 0.05). Representative histological images of HE-stained teeth, 28 days after pulp capping with MTA are 
shown (Supplemental Fig. 10). Each MMP molecule incubated alone (0.01–1 µg/ml) was used as an additional 
control and showed no effect on the direct pulp capping (Supplemental Fig. 10).
Discussion
Traditional direct pulp capping materials, such as Ca (OH)2 or MTA, have a 60%–80% success rate, as reported 
in clinical studies4,23,24. However, these materials were developed on a more empirical basis, rather than through 
specific understanding of the wound-healing mechanisms of the dentin-pulp complex. Recent studies have aimed 
to introduce bio-mimicked tissue healing with growth factors as a direct pulp-capping material25–27. However, 
limited effects have been observed regarding the healing of wounded pulp tissues as the wound healing mecha-
nisms of the dentin-pulp complex remain not entirely clear.
MMPs are calcium- and zinc-dependent, host-derived enzymes28 that can hydrolyse ECM components29. 
ECM integrity is affected by MMPs and TIMPs, which play critical roles during matrix remodelling9–11. Several 
MMPs have been reported to be sequestered in mineralized dentin30, and recent studies revealed that host-derived 
MMPs contribute to the breakdown of collagenous matrices during dental caries30. Conversely, MMPs have been 
reported to be involved in wound healing processes, such as cell growth, cell migration, tissue remodelling and 
angiogenesis31,32. We also previously reported upregulated MMP gene expression after pulp injury8 and MMPs 
have been detected in the dentin matrix in an inactive state33,34. The distribution of MMP molecules has been 
reported at deeper sites within the dentin, where they exhibit gradients of activity35–37. The presence of these mol-
ecules within the dentin-pulp complex enable them to activate DMCs released by bacterial acids or restorative 
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materials. These activated molecules may subsequently act in biological defence and repair processes within the 
tooth. Therefore, in the present study, we focused on MMPs that might facilitate matrix remodelling of dental 
pulp tissues or digested DMCs which promote wound healing21,37.
Figure 4. Effects of 1 µg/ml of dentin matrix components (DMCs) treated with matrix metalloproteinase 
(MMP)-1 (A), MMP-2 (B), MMP-3 (C), MMP-8 (D), MMP-9 (E), MMP-13 (F) and MMP-20 (G) on cell 
proliferation of rat primary pulp cells. Pulp cell proliferation was promoted by 1 µg/ml of DMCs treated 
with MMP-1 (A), -8 (D), -9 (E), or -13 (F), compared with incubated DMCs without the addition of MMPs 
(p < 0.05). Significant differences were not observed with 1 µg/ml DMCs treated with other MMPs, MMPs 
incubated alone or at lower concentrations (0.01–0.1 µg/ml) of the above mentioned MMPs (Supplementary 
Figure 6). Groups with similar lower-case letters (i.e., a and b) are not significantly different. Data represent five 
independent experiments.
www.nature.com/scientificreports/
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Dentin is a major component of the tooth and covers the dental pulp. It is considered to be part of the ECM 
of the combined dentin-pulp complex, rather than being a distinct tissue, as it originates from the same mesen-
chymal tissue38,39. However, the complete range of functions of dentin is still under investigation. During caries 
progression, dentin is demineralized by acids secreted by caries-associated bacteria, and DMCs may be digested 
enzymatically during this process40. Therefore, we investigated the effects of digested DMCs on wound healing of 
the dentin-pulp complex both in vitro and in vivo.
Protein analysis by SDS-PAGE showed DMCs were digested with MMPs-1, -2, -3, -8, -9, -13, and -20. The 
resultant protein profiles differed among MMPs (Fig. 1), which was as expected because of their differing sub-
strate specificities. Generally, MMP-1 has been considered as a collagenase and MMP-2 is reported as a gelatinase. 
However, MMP-1 is also able to degrade proteoglycans41 and MMP-2 reportedly can degrade and activate the 
DMP-1 protein, which is a key dentin matrix signalling protein42. In addition, non-canonical substrates have 
been identified as targets of these MMPs41. Similarly, MMP20 has been recognized as enamelysin and cleaves 
enamel-related proteins; however, further substrates could exist. Recently, MMP20 was reported to associate with 
the activation of DSPP, which is a member of the small integrin-binding ligand, N-linked glycoprotein (SIBLING) 
family43. Several previous reports have demonstrated that various proteins from the SIBLING family, along with 
several growth factors, are present in DMCs44–47. Therefore, DMCs may contain SIBLING substrates for MMPs.
Subsequently, we performed SDS-PAGE analysis and confirmed that DMCs extracted with EDTA could 
react and respond to the MMP molecules. These results suggested that MMPs may hydrolyse or facilitate dentin 
decomposition, consistent with the findings from these previous studies48.
Next, we examined the effects of DMCs digested with MMPs on the functions of primary pulp cells in vitro. 
DMCs digested with some MMPs promoted angiogenesis, migration, proliferation, migration, osteogenic 
Figure 5. Effects of 1 µg/ml of MMP-treated dentin matrix components (DMCs) on cell differentiation in 
rat primary pulp cells. Cells were treated with DMCs treated with matrix metalloproteinase (MMP)-1 (A,H), 
MMP-2 (B,I), MMP-3 (C,J), MMP-8 (D,K), MMP-9 (D,L), MMP-13 (E,M), and MMP-20 (G,N), incubated 
DMCs without MMP or medium alone containing 50 μg/ml of ascorbic acid and 10 mM of β-glycerophosphate 
for 7 days (A–G) or 14 days (H–N). One microgram per millilitre of DMCs treated with MMP-1 (A) or MMP-
20 (G) showed higher alkaline phosphatase (ALP) activities, compared with incubated DMCs without MMPs 
at 7 days (p < 0.05). On day 14, DMCs treated with MMP-9 (L) and -13 (M) also stimulated pulp cell ALP 
activity in addition to MMP-1 and -20 (p < 0.05). Significant differences were not observed with 1 µg/ml of 
DMCs treated with other MMPs, MMPs incubated alone, or at lower concentrations (0.01–0.1 µg/ml) of the 
above-mentioned MMPs. Groups with similar lower-case letters (i.e., a and b) are not significantly different 
(Supplementary Figure 7). Data represent five independent experiments.
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Figure 6. Effects of 1 µg/ml of dentin matrix components (DMCs) treated with matrix metalloproteinase 
(MMP)-1 (A), MMP-2 (B), MMP-3 (C), MMP-8 (D), MMP-9 (E), MMP-13 (E), or MMP-20 (F) on mineralized 
nodule formation in rat primary pulp cells. Cells were exposed to 1 µg/ml of MMP-treated DMCs, incubated 
DMCs without MMPs or medium alone containing 50 μg/ml of ascorbic acid and 10 mm of β-glycerophosphate 
for 21 days. DMCs (1 µg/ml) treated with MMP-1 (A), -9 (E), -13 (F), or -20 (G) significantly promoted 
mineralized nodule formation in pulp cell cultures after 21 days incubation (p < 0.05). Significant differences 
were not observed with DMCs treated with other MMPs, MMPs incubated alone or at lower concentrations 
(0.01–0.1 µg/ml) of the above-mentioned MMPs (Supplementary Figure 8). Groups with similar lower-case 
letters (i.e., a and b) are not significantly different. Data represent five independent experiments.
www.nature.com/scientificreports/
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differentiation and hard tissue formation. However, MMP molecules that promote wound healing in dental pulp 
cells may operate differently in vivo and the Cellular responses may be due to the target cells expressing different 
substrate binding sites for the MMP-digested DMCs. These in vivo outcomes may indicate variations in func-
tionality of the digested products from the same substrates according to the enzymes used to digest them; and 
Figure 7. Micro-computed tomography (CT) images of tertiary dentin formation 28 days after direct pulp 
capping using 1 µg/ml of dentin matrix components (DMCs) treated with matrix metalloproteinase (MMP)-1 
(A), MMP-2 (B), MMP-3 (C), MMP-8 (D), MMP-9 (E), MMP-13 (F), MMP-20 (G), or incubated DMCs 
without MMP (H). The tertiary dentin area 28 days after direct pulp capping using 1 µg/ml of DMCs digested 
with each MMPs showed in Fig. 7I. Quantification of tertiary dentin formation induced 1 µg/ml of DMCs 
treated with MMP-1, -9, -13, or -20 facilitated hard tissue formation, compared with 1 µg/ml of DMCs treated 
with other MMPs or incubated DMCs without MMP. One microgram per millilitre of DMCs treated with 
MMP-20 induced a significantly thicker tertiary dentin beneath pulp capping materials. One microgram per 
millilitre of DMCs treated with MMP-1, -9, and -13 induced tertiary dentin with some defect or void space 
beneath pulp capping materials. These data represent six independent experiments. C = cavity, D = dentin, 
P = pulp. White arrow = dentin bridge.
www.nature.com/scientificreports/
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this variation also agrees with previous reports49. Indeed, whilst we observed that DMCs digested with MMPs 
up-regulated some pulp cell responses in vitro (as described above) which associate with the wound healing 
response in the pulp tissue, it was however important to directly investigate whether MMP-digested DMCs 
invoked tissue healing responses in vivo, by using a direct pulp capping approach. Such an approach enables 
the evaluation of a more complete and simulated form of dental tissue repair and may also identify translational 
opportunities. Thus, we investigated the effects of digested DMCs on wound healing in pulp tissue by using direct 
pulp capping in vivo. The result of micro-CT analysis of hard tissue formation indicated that DMCs digested with 
MMP-20 induced highly condensed tertiary dentin beneath the pulp-capping materials applied (Fig. 7H,I) and 
histological images from the same specimen showed appropriate tubular dentin morphology (Fig. 8I). In contrast, 
DMCs digested with other MMPs induced tertiary dentin with more defects and void structures (Fig. 7A,E,F; 
Figure 8. Histological images (100×) of tertiary dentin formation 28 days after direct pulp capping using 1 µg/
ml of dentin matrix components (DMCs) treated with matrix metalloproteinase (MMP)-1 (A), MMP-2 (B), 
MMP-3 (C), MMP-8 (D), MMP-9 (E), MMP-13 (F), MMP-20 (G), or incubated DMCs without MMP (H). 
Higher magnification image (200×) of 1 µg/ml of DMCs digested with MMP-20 (I). 1 µg/ml of DMCs treated 
with MMP-1, -9, -13, or -20 facilitated hard tissue repair, compared with 1 µg/ml of DMCs treated with other 
MMPs or incubated DMCs without MMP, based on the rate of coverage of the exposed pulp by tertiary dentin 
(p < 0.05) (see online Supplementary Tables 1 and 2). In particular, 1 µg/ml of DMCs treated with MMP-20 
induced a significantly higher condense and more regular tubular structure. Significant differences were not 
observed with lower concentrations (0.01–0.1 µg/ml) of the above-described MMPs. These data represent 
six independent experiments. Arrows indicate dentinal tubules. C = cavity, D = dentin, DB = Tertiary dentin 
bridge, P = pulp.
www.nature.com/scientificreports/
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Tables 1 and 2). These results suggest that MMP20 may play an essential role in the pulpal healing process, com-
pared with other MMPs in vivo.
Given that wound healing in vivo is affected by a variety of complex and interacting factors, the results of in 
vitro experiments might not always mirror the in vivo processes. Furthermore, the source of MMPs in vivo is 
unclear and could be derived from variety of sources and locations, such as resident cells within the pulp and/
or the inflammatory infiltrate. A further potential explanation for the differences observed in vivo and in vitro 
may be due to the presence of other environmental factors, as it has been shown that ECM digested with several 
enzymes stimulated different actions, according to the environment studied50.
Most reports concerning MMP-20 have found that this enzyme appears to be predominantly expressed within 
the tooth51,52. Indeed, during tooth development, MMP-20 may contribute to enamel formation by digesting 
enamel-related proteins53. Additionally, MMP-20 is present in the dentin matrix and is expressed by odontoblasts 
in mature teeth and activated by dental caries progression17. Others have reported that MMP-20 is present in car-
ious dentin compared with sound dentin33. More specifically these reports relate to the localization of MMP20 in 
the dentin-pulp complex; however, there appear to be no reports of its biological role in this location. Data from 
the present study indicate that MMP-20 might be involved in a specific pulpal repair system enabling tertiary 
dentin formation.
For in vitro and in vivo experiments, MMP molecules alone were also used to investigate their direct effects; 
however, no direct effects on pulp cell function or pulpal tissue repair were observed. This outcome is likely due 
to the MMP molecule exerting no direct effect on these responses, or the inability to generate sufficient substrates 
in this environment due to the target molecules being embedded within the mineralized ECM. In addition, the 
most effective ratio of MMPs and DMCs is unknown. The concentration of MMPs in this study may not reflect 
the true biological environment as is present in dental caries. However, this study does indicate a potential role for 
MMP molecules in modifying or improving the local healing response of the dentin-pulp complex, via its action 
on DMCs. This model may therefore provide novel insight enabling the future elucidation of the mechanism 
involved in pulpal healing.
The different MMPs may also function at different doses; therefore, future studies are needed to deter-
mine optimal doses required. As MMPs have been reported to directly upregulate dental pulp through 
protease-activated receptors54,55, further investigation is also necessary to address this. In addition, other enzymes 
(e.g., serine or cysteine proteinases) are present in the dentin matrix56 and these proteinases may further degrade 
DMCs57. Thus, the effects of other endogenous enzymes during repair of the dentin-pulp complex should be 
examined.
Based on our findings, host-derived MMP may be involved in the wound healing process of the dentin-pulp 
complex (Fig. 9). During caries progression, initially enamel and then dentin is decalcified by bacterial acids 
and the organic dentin matrix is exposed (Fig. 9A). Subsequently, the dentin matrix is digested with MMPs, 
Histological evaluation
Grade Dentin bridge formation
0 No dentin bridge formation
1 Slight dentin bridge formation (dentin bridge formation covers 1/3 of exposed pulp)
2 Incomplete dentin bridge formation (dentin bridge formation covers 2/3 of exposed pulp)
3 Complete dentin bridge formation (dentin bridge formation completely covers exposed pulp)
Table 1. Criteria used for histological analysis of tertiary dentinogenesis.
Grade Dentin bridge formation
Material 0 1 2 3
Digested DMCs (MMP-1)* 1 2 2 1
Digested DMCs (MMP-2) 5 1 0 0
Digested DMCs (MMP-3) 5 1 0 0
Digested DMCs (MMP-8) 5 1 0 0
Digested DMCs (MMP-9)* 2 2 1 1
Digested DMCs (MMP-13)* 2 1 2 1
Digested DMCs (MMP-20)*,** 0 0 4 2
Incubated DMCs without MMP 3 2 1 0
PBS 6 0 0 0
Table 2. Grading results of the dentin bridge formation following the criteria of pulp histological consecutive 
sections 4 weeks after direct pulp capping (n = 6 per group). *1 µg/ml of DMCs treated with MMP-1, MMP-9, 
MMP-13, or MMP-20 stimulated pulp tissue repair, compared with 1 µg/ml DMCs treated with other MMPs. 
**In particular, 1 µg/ml of DMCs treated with MMP-20 resulted in significantly increased tertiary dentin 
formation, compared with all other MMPs. DMCs: dentin matrix components, PBS: phosphate-buffered saline; 
MMP, matrix metalloproteinase.
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which may be present endogenously (Fig. 9B), and dental pulp cells are activated by these MMP-digested DMCs 
(Fig. 9C). DMCs digested with MMP-1, -9, -13, and -20 facilitated wound healing of the dentin-pulp complex 
in our system (Fig. 9D). To our knowledge, this study is the first to examine the wound healing potential of the 
dentin-pulp complex by using DMCs digested with MMP-1, -2, -3, -8, -9, -13, and -20; the data identify a sig-
nificant role for MMP-20 in mature teeth. Further studies are necessary to analyse the components generated by 
digested DMCs and identify which molecules are critical for wound healing of this tissue.
Methods
Preparation of DMCs digested with MMPs. Human dentin specimens were prepared from extracted 
sound non-carious teeth (erupted, permanent dentition) collected from patients of both genders and all ages 
(generally 16–40 years) attending the Oral Surgery Department at Birmingham Dental Hospital (Birmingham, 
UK). Informed consent was obtained from all subjects. The protocols and all experimental procedures were 
approved by and performed in accordance with the relevant guidelines and regulations of the ethics approval of 
the University of Birmingham School of Dentistry Tooth Bank (Ethics approval no. 90/H0405/33) as described 
in a previous report58.
Briefly, after the tooth was extracted, pulp tissue and enamel were removed from the tooth by using dental 
instruments. The remaining dentin was pulverized into a powder by using a percussion mill (Spex 6700 Freezer/
Mill, Glen Creston Ltd, Stanmore, UK), then cooled with liquid nitrogen and filtered through a 60-μm mesh 
sieve. Powdered dentin was treated with a 10% (w/v) EDTA solution containing proteinase inhibitors, 10 mM 
N-ethylmaleimide (Sigma-Aldrich, Dorset, UK), and 5 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich) for 
14 days with agitation at 4 °C. The extraction solution was changed daily after centrifuging at 3,000 rcf for 10 min 
and the supernatant was collected. The pooled extraction supernatants were dialysed extensively against distilled 
water for 7 days and lyophilized by using a freeze dryer (Modulyo, London, UK). A dialysis membrane with a 
Figure 9. Proposed model for wound healing in pulp tissue following dental caries. Dentin decalcification 
initially releases matrix metalloproteinases (MMPs) from the dentin matrix during caries progression (A). The 
dentin matrix is then digested with MMPs (B). Dental pulp cells are subsequently activated by digested dentin 
matrix components (DMCs) (C). DMCs digested by MMPs, particularly MMP-20, stimulate wound healing in 
the dentin-pulp complex (D).
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molecular weight cut-off of approximately 12,000 kDa was used to maintain consistency among dentin matrix 
preparations59,60. The lyophilized powder was collected as intact DMCs.
Activation of MMPs was performed by treated with p-aminophenylmercuric acetate (APMA; Sigma-Aldrich) 
in the following experiments, according to manufacturer’s protocol. DMCs were treated with MMPs as follows: 
20 µl of each MMP (50 µg/ml) (MMP-1, -2, -3, -8, -9, -13, and -20) were added to 500 µl of intact DMCs (10 μg/
ml) and incubated for 1 h or 24 h at 37 °C in PBS (pH 7.4, Sigma-Aldrich, Dorset, UK). Ten micrograms per mil-
lilitre of DMCs was resuspended to 0.01–1 µg/ml of DMCs using each media following assay. MMP-1, -2, -3, -8, 
-9, and -13 were purchased from R&D Systems, Inc. (Minneapolis, MN, USA) and MMP-20 was purchased from 
Funakoshi Co. Ltd. (Tokyo, Japan). A 0.22-µm porous filter (Millex® GP, Merck, Billerica, MD, USA) was used 
for sterilization of the DMCs.
SDS-PAGE analysis. To evaluate the protein profiles of MMP-treated DMCs or incubated DMCs with-
out MMP addition, SDS-PAGE analysis was performed. After dissolving 1 μg/ml of digested DMCs in 
phosphate-buffered saline (PBS; Sigma-Aldrich), incubated DMCs without MMP in PBS, or an MMP-only solu-
tion of a specific MMP dissolved in PBS in loading buffer (Life Technologies, Carlsbad, CA, USA), the solution 
was denatured at 70 °C for 10 min. Then, 2 μl of the solution were loaded onto 4%–12% Bis-Tris gels (NuPAGE, 
Life Technologies) and electrophoresed at 200 V, 45 mA for 40 min with SDS running buffer (Life Technologies). 
The gels were stained by using a silver staining kit (Silver Xpress®, Life Technologies) according to the manufac-
turer’s instructions.
Cell culture. All experimental procedures were performed in accordance with the relevant guidelines and 
regulations of Osaka University, and all experimental procedures were conducted with approval by the Ethical 
Guidelines Committee for Animal Care of Osaka University Graduate School of Dentistry (No. 23–005–1). 
Primary rat pulp cells were collected from 6-week-old male Wistar rats (CLEA Japan, Inc., Tokyo, Japan), as 
has been previously described61. After upper and lower incisors were extracted under intraperitoneal anaesthe-
sia with sodium pentobarbital solution (Somnopentyl, Kyoritsu Seiyaku Corp., Tokyo, Japan) (30 mg/kg), pulp 
tissue was collected and minced by using a #12 scalpel and treated with 0.025% trypsin/0.01% EDTA solution 
(Sigma-Aldrich) for 30 min. Dissociated pulp cells were then cultured in α-MEM (Life Technologies) sup-
plemented with 20% (v/v) fetal bovine serum (FBS; Sigma-Aldrich) and 10 μg/ml of penicillin-streptomycin 
(Sigma-Aldrich) at 37 °C in a humidified incubator with 5% CO2 for 10 days. Primary pulp cell cultures of passage 
1 were used in subsequent experiments.
Angiogenesis assay. To evaluate the angiogenic effects of DMCs treated with MMPs, an endothelial 
tube formation assay was performed with the Angiogenesis Kit (Kurabo, Osaka, Japan). Human umbilical 
vein endothelial cells were co-cultured with human fibroblasts as a feeder layer containing 0.01–1 µg/ml of 
MMP-treated DMCs or incubated DMCs without MMP as an experimental control in angiogenesis induction 
medium (Kurabo). After incubation for 11 days, cells were fixed with 70% (v/v) ethanol for 30 min, then immu-
nostaining with CD31 (mouse anti-human CD31, Kurabo) to visualize endothelial cells of blood vessels. The 
acquired images were analysed by using Angiogenesis Image Analyzer V.2.0.5 (Kurabo) software to quantify the 
newly formed tubular formation, including vessel number, branch length and branch point in blood vessel-like 
structures (n = 3). Angiogenesis induction medium containing 20 μM/L of suramin was used as a negative control 
and recombinant human VEGF (2 ng/ml) was used as a positive control. The exact mechanism of suramin as an 
inhibitor of angiogenesis is not known; however, its non-specific interactions with numerous growth factors and 
angiogenic factors, such as basic fibroblast growth factor (b-FGF), platelet-derived growth factor, transforming 
growth factor, and VEGF, have been shown62. VEGF, as a promoter of angiogenesis, has been reported to regulate 
intracellular functions and activities by binding to receptors63. Each MMP molecule incubated alone (0.01–1 µg/
ml) was used as an additional control.
Migration assessment by wound scratch assay. An in vitro wound scratch healing model was used 
to investigate cell migration. Rat primary pulp cells (5 × 104 cells) were seeded onto 6-well cell culture dishes 
(Becton Dickinson and Company, Franklin Lake, NJ, USA) containing α-MEM supplemented with 10% FBS. 
When cells became sub-confluent, the medium was changed to α-MEM supplemented with 1% (v/v) FBS and 
cells were cultured for an additional 24 h. Then, 10 µg/ml of mitomycin-C (Calbiochem, San Diego, CA, USA) was 
applied to the medium for 30 min to remove the effect of proliferation and determine more specifically the role of 
migration in closure of the scratch wound by the cells. The experimental approach used here is based on previous 
studies, which have explored the roles of proliferation and migration in the wound closure assays64. An artificial 
scratch wound was created by disrupting the monolayer using a sterile plastic pipette tip. Medium containing 
0.01–1 µg/ml of MMP-treated DMCs or incubated DMCs without MMP as an experimental control were then 
added and cells were cultured for 36 h to allow migration into the wounded area. Cells not treated with DMCs 
served as a negative control. Each MMP molecule incubated alone (0.01–1 µg/ml) was used as an additional 
control. Eight points were randomly selected to assess migration; the distances of the cells from the edge of the 
scratch wound were averaged and statistically evaluated by microscopic observation (Fig. 3A) and compared with 
controls by using ImageJ software (Version 1.47, National Institutes of Health, Bethesda, MD, USA).
Migration assessment by trans-well assay. Cell migration (chemotaxis) was also evaluated by using a 
Boyden chamber (membrane pore size = 8 µm) (Cytoselect®, Cell Biolabs, San Diego, CA, USA)65. Rat primary 
pulp cells were seeded into the upper chamber in α-MEM containing 1% (v/v) FBS at a density of 2.0 × 104 
cells, and MMP-treated DMCs or incubated DMCs without MMP (0.01–1.0 µg/ml) as an experimental control 
in α-MEM containing 1% FBS were added to the lower chamber. After 2 h incubation, cells that passed through 
the membrane from the upper to lower chamber were removed by using cell detachment buffer (Cell Biolabs) 
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for 30 min. Then, CyQuant® GR dye (Cell Biolabs) was added to the lower chamber for fluorescent staining of 
migratory cells. Migration was quantified by using a microplate reader (ARVO MX, PerkinElmer, Waltham, MA, 
USA) at 485 nm/535 nm fluorescence intensity (n = 8 for each group). Cells not treated with DMCs in the lower 
chamber served as a negative control. Each MMP molecule incubated alone (0.01–1 µg/ml) was used as an addi-
tional control.
Cell proliferation assay. To evaluate the effects of MMP-treated DMCs on the growth of rat primary pulp 
cells, the WST-1 assay was performed. Rat primary pulp cells (1.0 × 104 cells) were cultured in α-MEM supple-
mented with digested DMCs (0.01–1.0 µg/ml) or incubated DMCs without MMP (0.01–1.0 µg/ml) as an experi-
mental control for 5 days. Then, WST-1 reagent (Roche, Basel, Switzerland) was added and cells were incubated 
for 2 h. The fluorescence at 450 nm was measured using a microplate reader (ARVO MX) to evaluate cell prolif-
eration (n = 6 for each group). Cells not treated with DMCs served as negative controls. Each MMP molecule 
incubated alone (0.01–1 µg/ml) was used as additional control.
ALP activity. Alkaline phosphatase (ALP) activity was measured to investigate the effects of digested 
DMCs on pulp cell differentiation66. Rat primary pulp cells were cultured with 0.01–1 µg/ml MMP-treated 
DMCs or incubated DMCs without MMP as an experimental control in α-MEM supplemented with 10 mM 
β-glycerophosphate (Sigma-Aldrich), 50 µg/ml ascorbic acid (Sigma-Aldrich), and 10% (v/v) FBS (differentiation 
induction medium) at a density of 2.0 × 104 cells/well. After 7- or 14-day incubation, ALP activity was measured 
with the Alkaline Phosphate Substrate Kit (Bio-Rad Laboratories, Hercules, CA, USA) according to the manufac-
turer’s instructions. Cells not treated with DMCs served as negative controls (n = 6 for each group). Each MMP 
molecule incubated alone (0.01–1 µg/ml) was used as an additional control.
Mineralization assay. Mineralization of rat primary pulp cells was evaluated by alizarin red staining (PG 
Research, Tokyo, Japan). Rat primary pulp cells (5.0 × 104 cells) were incubated in differentiation induction 
medium with 0.01–1 µg/ml of MMP-treated DMCs or incubated DMCs without MMPs as an experimental con-
trol for 21 days. Then, cells were fixed in 10% neutral buffered formalin and mineralized nodules were stained 
with alizarin red. The bound dye was quantified with a mineralization assay kit (PG Research) by measuring 
absorbance at 405 nm by using a microplate reader (ARVO MX). Specimens cultured in mineralization medium 
that were not treated with DMCs served as negative controls (n = 6 for each group). Each MMP molecule incu-
bated alone (0.01–1 µg/ml) was used as an additional control.
Direct pulp capping using rat teeth in vivo. The effects of MMP-treated DMCs on wound healing of 
the dentin-pulp complex were examined by direct pulp capping in 8-week-old male Wistar rats (CLEA Japan). 
After general anaesthesia, the pulp was exposed on the occlusal surfaces of maxillary first molars by using a #1 
round carbide bur (Dentsply Maillefer, Ballaigues, Switzerland), as previously described8,62. The size of the cavity 
measured approximately 1 mm in depth and 0.4 mm in diameter. The exposed pulp tissue was rinsed with saline 
and dried, then directly covered with a gelatine sponge (Spongel®, Astellas Pharma Inc, Tokyo, Japan) contain-
ing 20 µl of MMP-treated DMCs (0.01–1 µg/ml), or incubated DMCs without MMP as an experimental control. 
ProRoot MTA (Dentsply, Tulsa, OK, USA) was used as a positive control3,6,66. Each MMP molecule incubated 
alone (0.01–1 µg/ml) was used as an additional control. The cavity was then sealed with glass ionomer cement 
(Fuji IX, GC, Tokyo, Japan). Specimens with a gelatine sponge containing 20 µl of PBS served as negative controls 
(n = 6 for each group).
Twenty-eight days after pulp capping, rats were perfused with physiological saline followed by paraform-
aldehyde solution (Nacalai Tesque, Kyoto, Japan). Pulp-capped teeth were removed en bloc with surrounding 
maxillary bone and immersed in the same fixative for an additional 24 h. The induced tertiary dentin (n = 6 in 
each group) was analysed by using a micro-CT scanner (R_mCT2, Rigaku, Tokyo, Japan) at settings of 90 kV and 
160 µA with a scanning resolution of 20 μm intervals in individual image. After scanning, the area of induced 
tertiary dentin of each specimen was quantitatively analysed by using three-dimensional reconstruction images 
for bone (TRI/3D-BON; Ratoc System Engineering, Tokyo, Japan) with reference to previous report67,68. After 
confirming the consistency between micro-CT and histological images, image analysis was performed. Teeth 
were demineralized in a 10% (v/v) citric- 22.5% (v/v) formic acid solution (Wako Pure Chemicals, Osaka, Japan) 
for 1 week at 4 °C. The specimens were prepared by the previous protocol of graded alcohol dehydration, followed 
by paraffin embedding, and sagittal sections were prepared at a thickness of 5 µm for HE staining69. Wound 
healing of the pulp tissue was quantified based on tertiary dentin formation, as previously described70. Namely, 
conventional histopathological methods were used to analyse six consecutive sections from each sample. Defects 
in tertiary dentin could be generally observed around the centre of exposed pulp area due to tertiary dentin 
formation that began at the periphery of the exposed pulp tissue. Subsequently, we selected and evaluated six 
consecutive images from the central area of the tertiary dentin to determine the quality of tertiary dentin with 
reference to micro-CT images, based on previously published histological criteria. The criteria for histological 
evaluation were derived from previous publications71–73 and are shown in Table 1. For the histological evaluation, 
two independent observers were trained to evaluate histological features by using the designated criteria with 95% 
consistency referring to micro-CT images. If there was disagreement between the two observers, consensus was 
reached by discussion.
Statistical analysis. Significant differences were evaluated by one-way ANOVA with Tukey’s post-hoc test, 
the Kruskal-Wallis test, or the Steel-Dwass test. P values < 0.05 were considered statistically significant.
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Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on request.
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